Background/Purpose: To investigate the clinical features and visual outcomes of acute optic neuritis in adult patients. Methods: We prospectively collected ninety-nine adult patients, who were found to have acute optic neuritis between 2005 and 2007 at National Taiwan University Hospital. A total of 30 cases, aged ranging from 21 to 55 years old (average 36.4 AE 9.9), that followed up at least 6 months were enrolled in our study. Baseline clinical features and visual function results were analyzed. Results: The mean follow-up period was 15.6 months. Twenty three (76.7%) cases were female. Twenty-seven cases were unilateral involved, one was simultaneously bilateral involved and two was sequentially bilateral involved. In total 33 affected eyes, ocular or periocular pain was noted in 14 eyes (69.7%). Optic disc swelling was noted in 5 eyes (15.2%). A total of 6 cases had recurrent episodes, and two of them were diagnosed with multiple sclerosis thereafter. At 6-month follow up, 24 eyes (72.7%) had good visual recovery (better than 20/ 40). Only 2 eyes (6%) had severe visual loss (<20/1000). Optic disc pale was detected in 72.7% of the eyes during follow up. Conclusion: Visual recovery was observed in most eyes with acute optic neuritis, although disc pale detectable. Patients with recurrent optic neuritis had worse visual outcome. There was a low association of optic neuritis with multiple sclerosis in our patients.
Introduction
Optic neuritis (ON) is an inflammation of the optic nerve that usually affects young people ranging from 18e45 years of age, who eventually experience good visual recovery. ON can be a monophasic or polyphasic disease isolated to the optic nerve(s) or can be associated with a more widespread demyelinating disorder of the central nervous system such as multiple sclerosis (MS) or neuromyelitis optica (NMO). 1 In Western countries, natural history and treatment of ON and its relation to MS have been studied extensively. 1 Intravenous methylprednisolone may accelerate visual recovery in ON; however, it has no effect on long-term visual outcome. 2, 3 Most patients may retain good to excellent vision more than 10 years after an initial episode of ON. 3 But the long-term rate of conversion of ON to MS is high, ranging from 38% to 75%. 1 The presence of white matter lesions on the initial magnetic resonance image (MRI) of the brain has been identified as the strongest predictor for the development of MS. 4 Recent efforts have been made to identify the patients at high risk of MS and begin a disease-modifying drug at the time of a clinically isolated demyelinating syndrome such as ON to reduce the rate of development of MS. 1 In Asian countries, MS is known to present differently than in Western countries. It is characterized by the selective and severe involvement of the optic nerve and spinal cord as well as low prevalence rates. 5 It is not clear whether the natural history of ON occurring in Asians is, like that of MS, different from that of Western populations. In hospital-based case series, some racial differences were found in the characteristics of the disease. 6, 7 Moreover, the conversion rate of ON to MS in the Asian population was low. 7, 8 It is important to understand the clinical features of ON and their relation to MS in Asian patients. We prospectively followed up adult patients with acute ON, and its baseline clinical features at onset and visual outcomes were analyzed.
Patients and methods
From May 2005 to December 2007, we conducted a prospective clinical study to follow up the adult patients with acute ON at National Taiwan University Hospital. Inclusion criteria included patients older than 18 years with the clinical diagnosis of a first episode of unilateral or bilateral ON and willingness to sign informed consent for study and followup. The diagnosis of ON was defined according to the clinical criteria of Perkin and Rose 9 as "a condition causing a relatively rapid onset of visual failure, in which no evidence for a toxic, vascular, or compressive etiology can be discovered, and where local retinal lesions have been excluded" with clinical and radiographic examinations to rule out other causes of vision loss. The severity of visual acuity loss can be variable, but visual field defect, color vision impairment, and an ipsilateral afferent pupillary defect should be detected. Patients with a history of MS or any systemic disease that would make them unsuitable for long-term follow-up were also excluded. Institutional review board approval by the Ethics Committee of National Taiwan University Hospital was obtained.
Ninety-nine patients (potential study patients) in whom ON was diagnosed were identified. However, only 34 patients wanted to participate in long-term follow-up for at least 6 months; during this period, no further medication will be given. Among these patients, four were excluded because one was suspected of having anterior ischemic optic neuropathy, one was suspected of having orbital inflammation, one had a past history of recurrent ON, and one had unexplained bilateral loss of vision. Thus, a total of 30 adult patients with ON were enrolled in our study. These patients had received pulse therapy with intravenous methylprednisolone 250 mg every 6 hours for 3 days consecutively, followed by oral prednisolone for 1 to 2 weeks, to treat acute ON according to the protocol of the Optic Neuritis Treatment Trial 2 (ONTT). Recurrent attacks were defined as second ON episodes occurring more than 1 month later. Demographic data and baseline clinical features were recorded. Visual functions including visual acuity, color vision, and visual field were followed at acute onset and 6-month follow-up visit. Best corrected visual acuity (BCVA) was measured to full refractive correction using the Landolt C chart at a viewing distance of 5 meters, and the results of decimal acuity were calculated as the logarithm of the minimal angle of resolution (logMAR). Color vision was tested using pseudoisochromatic Ishihara plates (a total of 14 plates). Numbers of correctly recognized plates give a score of 0 to 14, with 14 considered normal color vision. Visual field was assessed using the Humphrey Field Analyzer (program 30-2) (Zeiss-Humphrey System, Dublin, CA, USA). Field loss severity was defined as: severe (mean deviation greater than -20.0 dB), moderate (mean deviation greater than -6.0 dB but less than -20.0 dB), and minimal (mean deviation greater than -3.0 dB but less than -6.0 dB).
The clinical features of the eyes that had visual acuity worse than 20/40 at 6 months were compared with that of the eyes that had visual acuity of 20/40 or better at 6 months, using the Fisher exact test.
Results
A total of 30 adult patients with ON were included in this study, ranging in age from 21 to 55 years (average 36.4 AE 9.9 years). The mean follow-up period was 15.6 months. There were 23 female and seven male patients (female, 76.7%). Twenty-nine patients were Chinese and one was a Vietnamese woman. During the follow-up period, Figure 1 Distribution of corrected visual acuity of affected eyes at disease onset and 6-month follow-up. six patients had recurrent ON (three in the same eye, two in the other eye, and one with relapse in one eye of the previously bilateral ON). Thus, a total of 30 patients (33 affected eyes), including 27 patients with unilateral ON, one with bilateral simultaneous ON, and two with bilateral sequential ON, were included in this study.
Ocular or periocular pain was noted in 14 eyes (69.7% of the affected eyes). Optic disc swelling was seen in five eyes (15.2% of the affected eyes). Six patients had recurrent episodes, all of them had retrobulbar type ON, and two of them had MS (one with opticospinal MS) 4 months after the onset of ON.
Visual acuity was measured in all 33 affected eyes. Fig. 1 showed the distribution of BCVA in the affected eyes during the disease onset and after 6-month follow-up. During disease onset, decrease in visual acuity was variable, but most patients had moderate to severe visual loss. Among 12 affected eyes with severe vision loss (< 20/1000) initially, nine had recovered visual acuity better than 20/40. At 6-month follow up, 24 eyes (72.7%) had good visual recovery (better than 20/40). Only two eyes (6%) had severe vision loss (< 20/1000). Patients who had longer follow-up showed stabilized vision after 6-month follow-up (Fig. 2) . When considering factors affecting the visual outcome, recurrent ON was calculated to be statistically significant ( Table 1 ). Although at least two thirds of the affected eyes had visual recovery better than 20/40, a pale disc was detected in 72.7% of the eyes during follow-up.
Color vision impairment was found in most of the affected eyes during disease onset, with 63.6% recognizing fewer than three plates during disease onset. In addition, 63.6% of the affected eyes had good recovery after 6-month follow-up (Fig. 3) .
Field loss pattern was presented with great variety. The most common type of visual field defect was diffuse depression (39.4%) and the most common type of focal field defect was altitudinal field defect at disease onset (Table 2) . Most eyes had severe to moderate field loss initially (Fig. 4) . In addition, 66.7% of the affected eyes had only minimal field loss or normal visual field at 6-month follow-up. Further visual field follow-up was available for 8 patients at 1 year, and 6 patients for more than 18 months. It showed that the visual field change was quite stable compared with 6-month data.
In two cases, demyelinating disease was diagnosed during the follow-up period. Case 1 was a 36-year-old male with recurrent retrobulbar ON. Opticospinal MS (OS-MS) was diagnosed 4 months after the first onset of ON. His vision declined to 20/200 and did not recover until the second episode of ON in the same eye. Case 2 was a 21-year-old female with recurrent retrobulbar ON. MS was diagnosed at 4 months after the first onset. Multiple relapses of ON occurred during follow-up, with two episodes in the same eye and one episode in the other eye. In each episode, she had severe visual loss in the affected eye. However, she Visual function in acute optic neuritis patientsrecovered good central visual acuity in both eyes, even though residual field defect and pale disc were present.
Discussion
We prospectively studied the adult patients with a first episode of acute ON. The clinical features were compared with previous retrospective studies in Taiwan and summarized in Table 3 . In our study, the mean age of onset was 36.4 years and 76.7% of the patients were female. The age of onset was similar to that in most of the Taiwan studies except for the report by Lin et al, 7 which collected patients with wider ranges in age. Compared with reports from Japan and the ONTT (Table 4) , patients in the Japan study had similar age of onset; in contrast, the age of onset was younger in patients in the ONTT. The percentage of female patients was lowest in the study by Lin et al 7 and higher in the ONTT and our study.
The incidence of bilateral ON was lower in our study in comparison with the Taiwan studies. Adult-onset ON is typically unilateral. Simultaneous bilateral acute ON has been considered rare, particularly in individuals without known systemic inflammatory or autoimmune disease. However, recurrent ON can occur in either eye. In our study, short follow-up time may give the result of lower incidence of bilateral involvement.
Ocular pain was reported in approximately 44-64% of the patients in the Taiwan studies, which was similar to findings in the Japan study. These findings differed from those in the ONTT; 92% of their patients had ocular pain.
Surprisingly, only 15.2% of patients in our series had disc swelling, which was lower than the ONTT findings (35%), and much lower than other reports (44-55%). This may be due to the early detection of ON, or because most of our cases were of the retrobulbar type. Disc swelling was not a factor in predicting the visual outcome in the ONTT 10 and our study (Table 1) . However, disc swelling was associated with a lower risk of MS in the ONTT. 4 In our study, most of the affected eyes had color vision impairment during disease onset. In addition, 63.6% of the affected eyes had good recovery. In the ONTT, almost all patients with decreased visual acuity also had abnormal color vision at disease onset. Even in patients with visual acuity of 20/20 or better, abnormal color plate testing was seen in 51.1% of the patients.
11
The presenting vision of ON was variable in all studies (Tables 3 and 4 ). The presenting field defect was also variable and the most common type was diffuse depression; this finding was similar in all of the studies (Tables 3 and 4) . Local field defect was also present with great variety. In our study, nine patients showed altitudinal field defect; however, altitudinal field defect was not a feature specific to ischemic optic neuropathy. Figure 4 Visual field loss of the affected eyes at disease onset and 6-month follow-up. Visual recovery was prompt in most patients (visual acuity better than 20/40 in 72.7% at 6-month follow-up) in our study, and better than the retrospective study in Taiwan (Table 3 ). This discrepancy may be because that retrospective study tended to include more long-term follow-up patients with worse visual outcome, and loss of good visual recovery cases. But this finding was worse than the ONTT results; visual acuity was better than 20/20 in 74% of patients, and 20/25 to 20/40 in 18% of patients after 10-year follow-up. 3 In our study, among 12 affected eyes with severe vision loss (< 20/1000) during the first episode of ON, 9 eyes had recovered visual acuity better than 20/40. In the ONTT, it was suggested that baseline visual acuity (worse than 20/200) was the best predictor for the 6-month visual acuity outcome. 10 Patients of the poor outcome group (visual acuity < 20/40) had more severe loss of visual acuity at baseline, and more often had a recurrent attack of ON within the first 6 months. However, they also suggested the strength of this association is more statistically rather than clinically important, because most patients with severe initial loss of vision still had good visual recovery. 10 In the study by Chang et al, 12 the initial BCVA had no positive or negative correlation with the final BCVA. 11 In our study, baseline visual acuity was not associated with poor visual outcome ( Table 1) .
Both central vision and visual field improvement were stable at 6-month follow-up and lasted longer in our study. Bee et al 13 found that visual acuity and color vision in the unilateral group started to improve within the first 2 weeks after treatment, and visual acuity was similar at 2 weeks and 1 year. In the ONTT, visual recovery generally begins within the first 2 weeks after the onset of visual symptoms. Most improvement occurs by the end of the first month. Patients with incomplete recovery at 6 months may continue to improve slightly between 6 months and 1 year of follow-up. 10 The mean annual incidence of ON was not low (33/ 100000), but the conversion rate of ON to MS was low in a population-based study in Taiwan. 14 This low conversion rate was also noted in hospital-based studies in Taiwan  (Table 3) . This result is different from that of the Western population, in which the conversion rate to MS is high, ranging from 38% to 75% with varied length of follow-up. 1 According to several studies, MRI is the most significant predictor of MS conversion. 1, 4, 7 Other identified risk factors included female sex, retrobulbar type of ON, elevated cerebrospinal fluid-immunoglobulin G index, and recurrent attacks. 7 In the ONTT, male sex and optic disc swelling were found to be associated with a lower risk of MS. 4 In our study, despite a higher percentage of retrobulbar ON, the MS conversion rate was still low. Therefore, retrobulbar type ON was probably not the main factor to explain the difference in MS conversion rate.
Another feature of MS in the Asian population is the selective and severe involvement of the optic nerve and spinal cord (OS-MS). 5 In the study by Lin et al, 7 approximately half of their patients with MS had abnormal MRI lesions in the spine instead of in the brain. Chang et al 15 also reported that 56% of the MS in Taiwanese patients was OS-MS. 15 In our study, MS was diagnosed in two patients, and OS-MS in one patient. Recent studies have proposed that the opticospinal form of MS may be identical to NMO by a serum autoantibody marker of NMO (antiaquaporin-4 antibody). 16 
Summary
Our prospective study found recurrent ON to be statistically significant in predicting the visual outcome and the overall visual prognosis. Patients with recurrent ON had worse visual outcome than patients with nonrecurrent ON. In addition, only a low degree of association of ON with MS was found in our study. The major limitation of this preliminary study was its small sample size and short follow-up time. 
